Feng Chen Selected Research

Patched-1 Receptor

1/2016	Heterozygous PTCH1 Mutations Impact the Bone Metabolism in Patients With Nevoid Basal Cell Carcinoma Syndrome Likely by Regulating SPARC Expression.
1/2015	Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Chen Research Topics

Disease

363	Neoplasms (Cancer) 04/2022 - 12/2002
69	Infections 01/2022 - 08/2003
60	Inflammation (Inflammations) 08/2022 - 12/2004
53	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2005
34	Necrosis 01/2021 - 11/2002
31	Neoplasm Metastasis (Metastasis) 06/2022 - 10/2004
27	Lung Neoplasms (Lung Cancer) 03/2022 - 12/2005
27	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 02/2006
25	Fibrosis (Cirrhosis) 05/2022 - 04/2002
24	Hypoxia (Hypoxemia) 04/2022 - 11/2005
23	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2009
23	Body Weight (Weight, Body) 06/2021 - 04/2004
22	Myocardial Infarction 01/2022 - 11/2002
21	Carcinogenesis 01/2022 - 06/2003
18	Sepsis (Septicemia) 07/2022 - 09/2010
18	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2003
18	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 08/2003
17	Stomach Neoplasms (Stomach Cancer) 07/2021 - 01/2012
16	COVID-19 06/2022 - 01/2020
16	Reperfusion Injury 04/2022 - 12/2009
16	Glioma (Gliomas) 01/2022 - 01/2011
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2003
15	Carcinoma (Carcinomatosis) 01/2022 - 07/2003
15	Hypertension (High Blood Pressure) 01/2022 - 05/2010
14	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 05/2006
14	Obesity 01/2021 - 08/2004
13	Type 2 Diabetes Mellitus (MODY) 06/2022 - 11/2006
13	Ischemia 01/2022 - 05/2008
12	Pain (Aches) 12/2021 - 05/2006
12	Disease Progression 11/2021 - 01/2010
12	Stroke (Strokes) 09/2021 - 10/2004
12	Melanoma (Melanoma, Malignant) 08/2020 - 03/2015
12	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 05/2009
11	Ovarian Neoplasms (Ovarian Cancer) 03/2022 - 08/2006
11	Insulin Resistance 12/2021 - 11/2006
11	Cognitive Dysfunction 11/2021 - 12/2019
11	Wounds and Injuries (Trauma) 09/2021 - 05/2006
10	Nasopharyngeal Carcinoma 04/2022 - 02/2012
10	Liver Neoplasms (Liver Cancer) 01/2022 - 02/2014
10	Heart Failure 01/2022 - 06/2011
10	Leukemia 07/2021 - 04/2005
10	Starvation 01/2021 - 06/2013
10	Rhabdomyosarcoma 01/2020 - 08/2005
9	Atherosclerosis 01/2022 - 02/2011
9	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 10/2004
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2021 - 05/2009
9	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020 - 11/2002
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 02/2008

Drug/Important Bio-Agent (IBA)

101	Proteins (Proteins, Gene)FDA Link 10/2022 - 12/2002
76	Pharmaceutical PreparationsIBA 08/2022 - 08/2005
72	Biomarkers (Surrogate Marker)IBA 04/2022 - 07/2005
52	MicroRNAs (MicroRNA)IBA 06/2022 - 05/2010
44	Messenger RNA (mRNA)IBA 06/2022 - 04/2002
35	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2003
32	Biological ProductsIBA 02/2022 - 08/2003
29	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022 - 10/2010
27	CytokinesIBA 08/2022 - 03/2005
24	EnzymesIBA 10/2021 - 11/2004
23	Therapeutic UsesIBA 11/2022 - 03/2005
23	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2004
21	LigandsIBA 04/2022 - 04/2004
20	Long Noncoding RNAIBA 06/2022 - 01/2014
19	LipidsIBA 10/2022 - 05/2006
19	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2005
17	AntigensIBA 01/2022 - 12/2002
17	Peptides (Polypeptides)IBA 11/2021 - 04/2004
16	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 02/2010
16	Contrast MediaIBA 01/2020 - 11/2002
15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 01/2010
14	Small Interfering RNA (siRNA)IBA 08/2022 - 05/2009
14	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 07/2009
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 06/2004
13	Interleukin-6 (Interleukin 6)IBA 04/2022 - 03/2011
13	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 09/2010
13	Phosphotransferases (Kinase)IBA 03/2022 - 01/2012
13	CollagenIBA 01/2022 - 11/2002
13	VaccinesIBA 01/2021 - 12/2002
12	hypericinIBA 06/2015 - 05/2006
11	Transcription Factors (Transcription Factor)IBA 05/2022 - 10/2004
11	Oxygen (Dioxygen)IBA 12/2021 - 01/2010
11	fosbretabulin (combretastatin A4)IBA 01/2020 - 03/2005
10	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 01/2009
10	Indicators and Reagents (Reagents)IBA 01/2020 - 04/2005
9	SolutionsIBA 05/2022 - 09/2011
9	CalciumIBA 01/2022 - 04/2010
9	6-methyladenineIBA 01/2022 - 01/2019
9	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2003
9	Interleukin-10 (Interleukin 10)IBA 01/2021 - 04/2010

Therapy/Procedure

156	Therapeutics 11/2022 - 02/2005
32	Drug Therapy (Chemotherapy) 08/2022 - 10/2008
21	Radiotherapy 01/2021 - 01/2012
20	Precision Medicine 01/2021 - 01/2012
19	Aftercare (After-Treatment) 03/2021 - 03/2005
18	Hematopoietic Stem Cell Transplantation 08/2021 - 10/2009
15	Transplantation 04/2022 - 11/2006
14	Lasers (Laser) 12/2021 - 10/2010
10	Immunotherapy 01/2022 - 12/2002
9	Electroacupuncture 11/2022 - 02/2007
9	Length of Stay 06/2021 - 09/2010
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2021 - 05/2005